Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Vectura

Explore full profile

Inhaled drug-device combination product development and manufacturing

Chippenham, United KingdomFounded 1997Biotech & Life Sciences
Valuation $393M Market cap · 2026
Revenue $252M Latest reported FY
EBITDA $73M Latest reported FY

At a glance

Founded
1997
Headquarters
Chippenham, United Kingdom
Listing
IPO 2008
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierThoroughbred$100M+ revenue

Latest news

Press, funding announcements and product moves mentioning Vectura.

See all news

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Excalibur Fund Managers

Series B and later1 investor entered at this stage

  • University of Bath
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
5 countries with
team presence
🇬🇧 United Kingdom94.3%
🇨🇭 Switzerland2.7%
🇫🇷 France1.3%
🇺🇸 United States1%
🇮🇪 Ireland0.7%
5 countries shown
Web traffic by country
650 monthly visits
across markets
🇬🇧 United Kingdom92.3%
🇳🇴 Norway15.4%
Top 2 markets shown

Patents

Estimated portfolio value
$212M

92 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where Vectura was the backer or acquirer, 2014–2021. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Vectura's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Vectura's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        3 of 3 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about Vectura on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Vectura on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.